News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Give today for a world immune to cancer – CRI
Photo taken from CRI/LinkedIn
Jun 22, 2024, 13:32

Give today for a world immune to cancer – CRI

Cancer Research Institute (CRI) shared on LinkedIn: 

“Join CRI ImmunoAdvocate Tara in celebrating discovery in cancer research, and donate today to double your impact!

Your gift will be matched up to $300,000 by a group of generous donors only until June 30, 2024.

Give today for a world immune to cancer.”

Proceed to video attached to the post.
Source: CRI/LinkedIn

cancer Cancer research Cancer Research Institute CRI donations ImmunoAdvocate OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic Day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Science
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?